Strategic Overview of Pricing and Reimbursement in the Major Markets

Title	Published	Price
Snapshots US Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Asia Pacific Pharma Sector Analysis By: RNCOS The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region \| more...	11/1/2009	$1,200.00
Pharmaceuticals Industry Report By: Plimsoll Publishing Ltd. The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial \| more...	11/1/2009	$1,500.00
Generic Pharmaceuticals Industry Report By: Plimsoll Publishing Ltd. The Global Generic Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth \| more...	11/1/2009	$1,500.00
Antipsychotics Market Forecast By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes By: Datamonitor Introduction Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest \| more...	10/20/2009	$5,700.00
Prescription Drug Wholesaling in the US - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Prescription Drug Wholesaling in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of \| more... Search inside this report	10/17/2009	$825.00
Pharmacies in Australia - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Pharmacies in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating \| more... Search inside this report	10/17/2009	$810.00
Pharmaceuticals Wholesaling in Australia - Industry Market Research Report By: IBISWorld Industry Market Research Synopsis This Industry Market Research report from IBISWorld provides a detailed analysis of the Pharmaceuticals Wholesaling in Australia industry, including key growth trends, statistics, forecasts, the competitive environment including market shares and the \| more... Search inside this report	10/16/2009	$790.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 2